Dec 11, 2019 - Top Research Reports for Novartis, AbbVie & Sanofi
Dec 11, 2019 - The FDA accepts Roche's (RHHBY) allergic asthma drug Xolair's sBLA for the treatment of nasal polyps in adult patients aged 18 years or above with inadequate response to intranasal corticosteroids.
Dec 10, 2019 - increasing M&A deals and cutting edge therapies are driving biotech ETFs higher
Dec 10, 2019 - Sanofi (SNY) to prioritize key growth drivers, improve operating efficiencies and generate cost savings. The company discontinues R&D activities in diabetes and cardiovascular segments.
Dec 09, 2019 - Gilead (GILD) announces positive long-term data from a mid-stage study on Yescarta in adult patients with refractory large B-cell lymphoma.
Dec 06, 2019 - Biogen (BIIB) divulges new positive data on Alzheimer's candidate, aducanumab at CTAD. Stock rises.
Dec 06, 2019 - Regeneron (REGN) announces positive top-line data from a phase II study on rare blood disorder drug.
Dec 02, 2019 - Novartis's purchase comes with investigational cardiovascular drug inclisiran, a competitor with potential to dethrone Amgen's already embattled Repatha.
Nov 29, 2019 - Here's why the FDA recently approved five new drugs way ahead of schedule.
Nov 28, 2019 - IMO 2020 sulfur regulation goes into effect January 1, 2020.Frontline has chosen a scrubber strategy.Euronav has chosen a pre-purchase at bulk prices and store compliant fuel.The most economical strat